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Objective: Despite the increased patronage of herbal medicinal products 
(HMP), they remain poorly regulated in Ghana and their efficacy and safety 
data is seldom adequate. The objective of the present study is to provide 
insight into concerns regarding post-market HMP safety and efficacy from 
the perspectives of users in Kumasi, Ghana.  
Methods: Thirty-seven randomly selected HMP consumers in Kumasi, were 
interviewed using semi-structured questionnaire. Non-users of HMPs and 
users less than 18 years were excluded from the study. Mixed method 
sampling method was used for the study. 
Results: HMPs were reported to be gentle and safer than orthodox 
medicines by informants. Only 19% of informants voluntarily reported HMP 
use to their general practitioner. Informants (94.6%) experienced minimal 
effects, whiles (5.4%) experienced moderately severe adverse effects.  
Conclusion: It was observed from the study that some HMPs are however 
non-effective and harmful. We would suggest that HMP users should 
exercise caution with regards to where to buy and when using HM. 
“Shyness” and the “feeling of being condemned by the physician” were 
identified to be the possible causes of the communication barrier between 
the physicians and the HM users. We recommend physicians to initiate 
discussion on this topic during consultations and guide users on safe use of 
these HMPs. 
Keywords: Experience; Participants; Communication; Interview; Herbal 
medicine; Herbal medicinal product
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The use of herbal medicines (HMs) is widespread. 
Herbal medicinal products (HMPs) are usually used for 
preventive, curative and for chronic disease 
management [1,2]. The surge in patronage in the last 
decades is thought by some researchers to be due to the 
perceived efficacy and increased trust in the HMs [3,4]. 
Despite the perceived efficacy, available scientific 
evidence questions the efficacy of HMs. Bent [5] found 
little scientific evidence regarding the efficacy and 
safety of most of the over 2000 HMPs available and 
consumed in the US. Recently, Wilmot and colleagues 
discovered that all the top-5 most patronized 
antimalarial herbal preparations of the Greater Accra, 
Western and Central regions of Ghana had efficacy 
levels below the WHO standard [6]. In the same study, 
40% of the top-5 antimalarial preparations were found 
to have been adulterated with chloroquine. 
There is a huge public misconception regarding the 
safety of HMs as many construe ‘natural’ as ‘safety’ 
[7,8]. There are problems with batch variations, dosage 
and concentration inconsistencies of the active 
ingredients with some HMPs on the market [9]. A case 
series study in Belgium on Chinese herbal product for 
weight loss revealed that the product led to the 
development of end-stage renal failure, urothelial 
carcinoma and prophylactic kidney removal [10]. In 
another study, 28.8% of herbal preparations 
investigated were found to be contaminated with heavy 
metals and 7% of the herbal products were consciously 
adulterated with conventional drugs to improve efficacy 
[11]. 
HMs though, are perceived to be generally safe, they 
can pose health risk to consumers [12]. There have been 
reports of deaths and adverse effects such as 
cardiotoxicity, psychosis, hepatotoxicity and 
nephrotoxicity after administration of HMs [13-15]. 
HM and its supplements account for 25% of drug-
induced acute liver damage that result in liver transplant 
or death in the US [16-18]. Inherently toxicity, 
deliberate or inadvertent adulteration, microbial 
contaminants and pesticides have been linked with 
toxicities reported with HM usage [17]. Current policies 
safeguard not the safety of patients from potentially 
unsafe HMPs [18]. In Ghana, effort is being made by 
regulatory authorities to register HMPs before they are 
introduced into the market to safeguard public health. 
As part of the effort, the Traditional and Alternative 
Medical Practice Council (TAMPC) was established 
with the mission of promoting, controlling and 
regulating the practice of Traditional and Alternative 
Medicine in Ghana. Despite the creation of TAMPC, 
many HMPs still get to the market through the back-
door and without safety evaluation. There has not also 
been regular field post-market safety and efficacy 
surveillance on both registered and unregistered HMPs 
in the market thereby creating a major public health 
concern. 
In Ghana, most consumers fail to report cases of adverse 
health effects associated with the use of HMPs and 
herb-drug interactions there is also lack of zeal and 
motivation on the part of the consumer or lack of formal 
systems established by authorities to encourage the 
reporting of such cases. There is, therefore, paucity of 
data on HMPs associated adverse health reactions and 
consequences of their interaction with food and 
orthodox medicines in Ghana. The true state of side 
effects for most HMPs on the Ghanaian market is 
unknown, requiring the need for regular monitoring 
studies [5]. The primary aim of this post-market 
surveillance, therefore, was to obtain in-depth 
understanding and insight into concerns regarding 
efficacy and safety of HMPs from the perspectives of 
the consumers. 
Methods 
Pre-study feasibility interviews were carried out on 10 
participants (informants) prior to the main study to fine-
tune the interview guide.  Transcripts of the pre-study 
trials were not added to the main study. In the main 
study, face-to-face semi-structured interviews were 
conducted on 37 information-rich users of HMPs (age ≥ 
18 years). Interviews were conducted with the help of 
an interview guideline.  
Sampling method 
A simple random and cross-sectional methods were 
used for this study. Herbal centers and clinics were 
randomly selected. Herbal medicine users were 
randomly recruited from the streets and central market 
of Kumasi. At the herbal clinics, all patients who 
patronized the centers between 10:00 to 16:00 from 
Monday to Friday during the study period (4th July to 
12th August 2017) were contacted and those who met 
the inclusion criteria and agreed to partake in the study 
were recruited (opportunistic/cross-sectional method). 
To be recruited in the study, the individual needed to be 
18 years or over, a user of HMPs, agree and sign a 
consent form and being able to communicate in at least 
English or Akan language. Background to the study was 
provided in the invitation letter including the need to 
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grant 30 minutes interview time if they agreed to 
participate in the study. The HMPs users who agreed to 
participate in the study upon receipt of the invitation 
letter were given consent form. The form provides 
detailed information about the study, voluntary 
participation and freedom to opt out at any time of the 
study. Possible risks and benefits of participating in the 
study were also detailed in the form. The interviews 
were conducted in English or Akan language depending 
on the preferences of the interviewees. Interview 
questions were structured in order of topic and were 
predominantly open-ended questions. The face-to-face 
interview lasted for about 25-30 minutes. The 
interviews were supplemented with audio recordings 
which were later transcribed into text for analysis. 
Ethical clearance for study was issued by the University 
of Cape Coast Institutional Review Board (UCCIRB) 
(UCCIRB/EXT/2017/07). 
Data analysis 
The closed-ended questions including socio-
demographic data in the study transcript were analyzed 
with IBM’s SPSS version 21 using frequency 
descriptive statistical analyses. The coding and code 
classification feature of RQDA (R package for 
computer-assisted qualitative data analysis) version 
3.4.4 run on R-studio 1.0.153 platform and the 
networking feature of Gephi were explored for the 
thematic qualitative data analysis. Braun and Clarke’s 
six steps to thematic analysis process were followed 
[21,22]. The interview transcripts were organized into 
two levels of organization; codes and code categories 
(themes). Transcribed data were read severally by the 
researcher for familiarization with the data. A total of 
47 codes with 365 initial markings were made after the 
first coding stage (Table 1).  




Familiarizing with data Transcribing data, reading and rereading the data, noting down initial ideas. 
Generating initial codes Reading and re-reading led to the generation of a total of 365 codes 
Searching for themes The generated codes were grouped under initial 47 code categories (themes). 
Defining and naming 
themes 
  
A total of 10 code categories (themes) were finally generated after the continual 
analysis, defining and refining the specifics of each theme and the overall story and the 
aim of the study. The final codes were also stratified based on income level and sex of 
respondents 
Producing the report The final findings were compiled into writing the report. 
Mixed inductive and deductive approaches to thematic 
analysis were used whiles following the six-step process 
by Braun and Clarke [19]. Most themes were 
inductively generated entirely from participants’ 
responses whiles some few priori deductive themes 
from previous research were added. The themes (code 
categories) and codes were revised to contribute in 
answering the research question; some themes (code 
categories) and codes were deleted, merged and or 
renamed to best suit the study (Table 1 and 2). 
Recoding, renaming, dropping or adding of codes and 
code categories continued during the preparation and 
drafting of the results. Case categorization was done on 
the transcripts to categorize the transcripts based on sex 
and income level for easy case retrieval of the opinion 
of male or females and the effect of income on a theme. 
Sox major themes with sub-themes emerged from the 
study (Figure 1). Interviewees were randomly given 
codes ranging from H1 to H37 for anonymity. From 
hence, interviewees are represented in the text with 
these codes H1, H2….H37.  
Results 
Socio-demographic characteristics of participants 
Most participants (59.5%) were males, informants aged 
from 23 to 80 (mean age 47.8 ± 14.2). Most participants 
were educated; 18.9% had tertiary education, 40.5% had 
received either secondary, A-level, O-level or 
equivalent form of education, 27% had received 
primary level of education while the rest had no formal 
education. In this study, 27% of the participants lived 
below the international poverty line of GH₵ 342 per 
month ($1.9 per adult a day of the World Bank’s 
international poverty line at the time of the study using 
Bank of Ghana rate). The remaining 73% had monthly 
incomes either equivalent to or above the international 
poverty line. Over 81% of informants reported to have 
never drank alcohol before, 16% drink moderately 
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during occasions or before meals while only 3% 
reported of going binge sometimes. None of the 37 
interviewees reported having smoked before. Over 70% 
of the informants have used HMPs for 2 or more years, 
and 73% of these individuals use HMPs routinely with 
or without conventional medicine for their health care. 
Theme 1: Efficacy of herbal medicine-(efficacy) 
The expression and rating of efficacy in real life 
situations were difficult with some elements of 
subjectivity and relativity especially for medicines with 
holistic effects. Four sub-themes evolved from efficacy. 
Efficacy from user s’ perspective-(Experienced) 
Many informants 59.46% believed the HMPs they used 
were efficacious. ‘‘When I was a kid, an herbal product 
was specifically prepared for me for skin problem and it 
really worked for me. The skin problem has never 
return’’ (H6). Others opined that, though HMPs are 
effective, the efficacy is only realized if you buy a good 
HMP. ‘‘HMP is effective, should you get a better one, 
but if not, it will give you problems and will not work’’ 
(H13). 
Eleven (29.7%) users believed HM is more effective 
than orthodox medicine. ‘‘I used it to heal my mum 
when she was sick and was not responding to allopathic 
treatment and pharmacy drugs’’ (H37). ‘‘Herbs work 
better than pharmaceuticals’’ (H19). Slow but sure: 
Some users believed HM has long-lived effect and cure 
their illness, but it takes a longer time to realize the 
effect compared to orthodox medicine while orthodox 
medicine has a short-lived effect. ‘‘HMP takes long 
time to see the effect but it can cure the sickness 
completely, pharmacy drug is quick, but the sickness 
might come back’’ (H33). ‘‘My mother was cured by 
herbal medicine after several hospital attempts’’ (H5). 
‘‘Like my pressure, if I take the doctors’ medicine it 
works but to return shortly after I stop using the drug. 
On the contrary, it takes about 6 months for it to return 
after using herbal medicine, HM really works; herbs can 
cure but pharmacy drug is for management’’ (H36). 
‘‘…the doctor’s medicine works but the sickness comes 
back shortly thereafter’’ (H28). 
Signs of HM efficacy; users’ experience-(Signs) 
Informants in this study used different endpoints/ signs 
to express HMP efficacy. ‘‘My blood sugar level 
reduced a little after taking the HMP (observed through 
regular diabetes check-up in a public hospital)’’ (H3). 
‘‘My ulcer stopped in two months instead of the three-
month timeline for treatment’’ (H24). Interviewees H18 
and H20 also reported that, ‘whenever they had malaria 
and they administered HM, it stopped’. Others used 
unusual signs and belief to express HM efficacy. ‘‘I 
started sweating after taking it and I believed it is a sign 
that it is working’’ (H26). ‘‘The pain increased after 
HM administration and I believed it to be a sign of 
healing the pain; for a HM to heal, it will first increase 
the problem and then heal them all” (H16). 
Negative perspective on efficacy of herbal medicine-
(Ineffective) 
Six users (16.2%) were dissatisfied with the HMP they 
used. ‘‘HM have not helped me, I have used many, but 
less help, they are not effective, most of the distributors’ 
claims are not true’’ (H35). ‘‘HM has not helped me at 
all, it did not work for me at all!’’ (H27). ‘‘They brag a 
lot on the radio and charges a lot, but their herbs do not 
work for me, …they are too expensive, and they do not 
work either’’ (H29).  
Theme 2: Assessing cost and cost-effectiveness of 
HMPs-(Cost-effectiveness) 
Two sub-themes emerged under how users see the cost 
of herbal products they used, namely cost of herbal 
medicine and cost-effectiveness from users’ 
perspective.  
Cost of herbal medicines-(Cost)  
There were two different opinions on cost; the first 
opinion was that HMs are generally less expensive and 
21.17 % users have such opinion. ‘‘The HMs are 
usually within my means, I think they are even a bit 
cheap’’ (H9). ‘‘It is always given to me by a friend, I 
don’t buy them, I just give him something small (small 
money) for transportation’’ (H4). ‘‘HMs are less 
expensive’’, said H17. The second group of the 
interviewees saw HMs to be slightly expensive. ‘‘Some 
HMPs are a bit expensive’’, (H20). ‘‘…they are 
expensive, some are around ₵200 GH’’ (about 50 $ 
USD) (H25). ‘‘Some are very expensive, too expensive, 
they have made me poorer’’ (H29).  
Cost-effectiveness from user’s perspective-(Cost-
effective) 
Considering the per-unit cost and the realized efficacy 
of HMs by users, some users believed HMs are less 
cost-effective. ‘‘Yes, I experienced mild stroke, went to 
the hospital about 4-times with two different laboratory 
tests, but there was no good outcome. But after 
switching to HM, I can now write and do most of the 
things I used to do again and are less expensive too’’ 
(H22). ‘‘I mostly buy moderate ones, HMPs are very 
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effective. I use it for all kinds of my health problems. 
Even yesterday I was feeling uneasy but after taking 
Adwutwumwaa capsules, I am now okay’’, (H30). A 
few informants believed that, the HMPs they used were 
not cost-effective. ‘‘It did not help me in anyway; they 
have also ended up taking all my pension money as a 
retired teacher without the sickness getting better’’ 
(H27). ‘‘No, it did not help me, used many but not much 
help. There had been a time I walked out of an herbal 
clinic when I was having an eye problem and they said 
I should pay ₵700 GH (175 USD) before they start the 
medication’’ (H35). 
Theme 3: Users’ belief and perception about herbal 
and orthodox medicines-(Belief and perception) 
Many interviewees believed HMs are more effective 
than orthodox medicines and that HMs can cure the 
sickness while orthodox medications are for 
management. They also iterated that HMs are a “slow 
but sure” way of treatment while orthodox medicines 
are quick in action but have short-lived effects. 
Comparison of the efficacy of the two has been detailed 
above under efficacy theme. Some users also opined 
that, HMs are natural and safer than pharmacy drugs.  
HMPs are natural, non-chemical and safer than 
pharmaceutical medicine-(Non-chemical) 
Thirty-five percent believed HMPs are natural, non-
chemical and safer than orthodox medicines. ‘‘It 
(HMPs) is naturally extracted from plants and we 
believe it is more effective with less bad side effects’’ 
(H11). ‘‘I believe the components are natural, so safe’’ 
(H12). ‘‘It is good for human consumption, because it 
helps the human system’’ (H8).   
Trust in HMs and pharmaceutical medicine (Trust) 
Trust in HMs has increased over the years based on 
many reasons and a few were shared by interviewees. 
HMs are safer and efficacious than orthodox medicine 
have been discussed previously and were also seen as 
factors for increased trust in HMs. In addition, 
dissatisfied with conventional medicine and tradition 
handed down were identified as other contributing 
factors. Trust in HMs come at the expense of decreased 
trust in conventional health care system. Eleven 
informants (29.73%) had such perception. ‘‘For some 
sicknesses, the doctor’s medicines do not work but 
some herbal medicines do’’ (H36). ‘‘If I use HMPs, it 
helps me a lot, so I use it based on previous experiences 
because the doctors’ medicine works but the sickness 
comes back shortly thereafter’’ (H28). ‘‘Most of the 
pharmaceutical medicines do not give you the results 
you are looking for, that made me go for herbal 
medicine’’ (H22). 
Herbal medicine is a tradition handed down-
(Tradition)  
A class of users (27.03%) had built trust in the HMs and 
feel at home using HMs, believing that it is a tradition 
handed down from their parents and grandparents. 
‘‘HM is the tradition of our grandparents, so we just feel 
at home when using it’’ (H2). ‘‘Cultural linkage from 
our parents and grandparents, when we were kids, our 
grandparents were giving us ‘dudo’ (a concoction or 
stock of herbal preparation which is home prepared, 
reheated every morning and used regularly by all 
members of the family)’’ (H1). ‘‘… from an herbalist 
grandfather, I use it because we believe they do not have 
bad effects like the pharmacy drugs.’’ (H15).   
Theme 4: Concerns about and fake sub-standard 
HMPs-(Sub-standard) 
Fake or sham preparation is a major concern for both 
herbal and orthodox medicines especially in developing 
countries. Fake and adulteration of HMPs was seen by 
many interviewees to be a major concern and some 
informants shared their displeasure.  
Fake and adulterated HMPs-(Fake) 
‘‘There are also fake HMPs on the market that is why 
the Ghana Food and Drugs Authority (FDA) should do 
a serious test... The FDA should help clean the market 
of fake drugs’’ (H1). ‘‘My concern is that there are fake 
ones, if you get the right HMP, it works’’ (H19). ‘‘I 
suspected an herbal mixture I took to have been 
adulterated, the taste and smell felt like it has been. It 
tasted like there were paracetamol and ‘biiko’ (the 
common name in Ghana for B-complex vitamin tablet) 
inside’’ (H24). 
Proliferation of HMPs primarily for business and 
profit-(Proliferation) 
Some informants believed that, some HMP producers 
are into the herbal industry solely for monetary gains 
and less concerned about the health of the patients. 
‘‘Many just want to make money; they pick any herb 
and call it HM’’ (H36). ‘‘There is no sanity these days 
in the market, everyone is selling or making HMP, they 
are much concerned about making money and not about 
healing people’’ (H23). ‘‘My concern is that there are 
too many HMPs on the market, they have been in-fluxed 
with fake ones’’ (H1). 
Concerns about claims by HM vendors-(Claims) 
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It was observed that some informants had misgivings 
concerning the claims of the HMPs’ vendors. ‘‘The 
vendors brag a lot on the radio and charge a lot of 
money, but their herbs do not work for me, they 
sometimes lie about free screening, but you may leave 
there paying about ₵500 GH ($125 USD)!’’ (H29). 
‘‘There are a lot of fake HMPs, not all are true, not 
effective, most of their claims are not true’’, (H35). 
Interviewees H10 and H32 complained that some 
vendors sometimes give false information to the public. 
Theme 5: Safety concerns of HMPs-(Safety 
concerns) 
Five sub-themes emerged as we discuss the safety of 
herbal medicines.  
The practice of combined herb-drug administration 
by users-(Poly-pharma) 
According to some users, HMs cure diseases but at a 
slow pace, so they administer HMPs after orthodox 
medical treatment to completely cure their sickness. ‘‘I 
do not usually combine different medications, but if I 
do, I first ask or request from a doctor or vendor before 
doing it (H7). “I use HMP and ACT combination 
therapy for malaria’’ (H12).  
Adverse effects of HMs from users’ experience-
(Adverse events) 
Adverse health effects encountered by some informants 
were reported by 27.03% of interviewees. ‘‘I have now 
developed swollen stomach and have kidney problems 
according to my doctors report which hitherto were not 
there’’ (H25). ‘‘I experienced an increase in a heartbeat 
when I ate shortly after herbal medicine 
administration’’ (H9). ‘‘It has increased my blood 
pressure, … it made my sickness go up, it could have 
killed me!’’(H27). Other reported side effects were 
headache and dizziness (H10 & H35), stomach pain and 
nausea (H11), migraine (H29) and constipation (H34). 
Adverse health effects of HMs based on hearsay-
(Hearsay) 
There are several unconfirmed ‘hearsays’ about HMs in 
Ghana, and below are few of such reports from 
informants. ‘‘I know of a man who has been in the UK 
for many years, but when he came home (Ghana) for a 
short stay, a HMP was given to him for piles which he 
took orally. Shortly then after he complained of 
excruciating pains in the mouth, the tongue started to 
swell and was coming out. He died shortly after being 
admitted into a hospital’’ (H1). ‘‘You sometimes hear 
reports of adverse health reactions emanating from 
HMPs usage especially from those bought in buses’’ 
(H13). 
Labelling and dosage concerns of HMPs-(Labelling) 
Labelling and dosage information are crucial for safe 
use of medications. Some users had concerns with 
labelling of some HMPs on the market. ‘‘Sometimes the 
labels give ambiguous statements; not clear statements. 
Also, they claim one HMP can heal many diseases, it is 
my concern’’ (H12).  
Some important dosage lapses evolved from the reports 
of 24.32% informants; ‘‘you can drink (HMs) as much 
as you want without any side effects’’ (H14). ‘‘The 
spirits direct me to the dosage to use, the spirits direct 
me to the herbal plant (medicine) to administer even to 
others, they direct the dosage to give and they never 
make mistake’’(H37).  
Other safety concerns raised-(Emerged) 
Other safety issues emerged during the interviews from 
the reports of 8 interviewees. ‘‘My only concern is the 
pesticides they use these days in spraying the plants, 
some farmers just spray any amount on the field without 
much knowledge like me. This issue raises concern 
about HMPs’ safety these days. The pesticides could be 
blamed for all these sicknesses’’(H2). ‘‘Some of the 
herbal medicine may be harmful somehow because they 
stay too long in the shells at the shops’’ (H14).  
‘‘You may die from pharmaceutical medicines overdose 
… but you will never die from HMs overdose. Michael 
Jackson is an example of pharmaceutical drug 
overdose’’ (H9). 
Theme 6: Reporting usage and safety issues to 
General Practitioner-(Reporting to GP) 
About half of users said they will report adverse effects 
and usage of HMPs to the general practitioner (GP) 
while only 19% said they will not report adverse effects 
to the GP. On the contrary, most informants said they 
will not voluntarily tell the GP that, they are using HMs; 
they either felt shy or afraid of being condemned by the 
GP. Three sub-themes evolved under this theme.  
Reporting HMP usage to the GP-(Feeling shy) 
Free flow of information is crucial for patients to be 
guided about the safe and rational use of HMPs. 
Doctors, according to interviewees, usually failed to ask 
them if they were using HMs during hospital visits, 
although the HMs users (10/37) were willing to disclose 
such information when asked. ‘‘If the GP asks, I will tell 
him, though I feel shy to freely tell him myself and 
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afraid of being condemned’’, (H27). ‘‘If the GP asks 
me, I will tell him but if he doesn’t ask me, I will not’’, 
(H14). ‘‘I will so that the GP can advise me whether to 
continue or discontinue using the HMP’’ (H36).  
Condemned by general practitioners for using HMs- 
(Condemning)  
Some users felt that the GP will condemn them and the 
HMP they are using if they should tell the GP during 
hospital visitation. ‘‘Sometimes you tell the doctor and 
he reply by saying, HMPs are not good. As for the 
doctors, they will condemn you and the HMP you are 
using’’ (H1). ‘‘I feel shy. I feel that the doctor will 
condemn me for using HMP’’ (H27). ‘’I feel the doctors 
will insult me’’ (H29).  
 
 
Figure 1: Thematic map. A plot showing the 
connection between the codes (sub-themes) and code 
categories (themes) generated with Gephi. The distance 
between the vertices and the sizes of the vertices are not 
to scale. The vertices larger in size represents themes 
and the vertices smaller in size represent codes or sub-
themes in this study. The lines are edge lines 
representing connection between either code-code, 
code-code category or code category-code category 
connections. Key: GP represents General practitioner. 
Reporting adverse events to GP-(Adverse events)  
Though many interviewees (10) felt shy to freely tell 
their GP that they were using HMs, about 50% were 
rather willing to report the side effects freely to the GP. 
Informants H2 and H7 commented that, they will report 
the side effects to the physician and they will not keep 
it to themselves, so that, the GP could give them 
guidance to relief the side effects. ‘‘You need to (report 
the side effects), so that the doctor can guide you, and 
will help him also in the prognosis’’ (H22). ‘‘Yes, so 




Figure 2: Codes retrieval based on sex and income level 
of informants, n=37. 
Discussion 
In this study, we obtained some insight into the efficacy 
and safety of some commonly used herbal medicinal 
products (HMPs) in Kumasi, Ghana, from the 
perspectives of the users. This is relevant in informing 
or promoting rational use of HMP, improving public 
enlightenment and possibly informing coherent policy 
that will further promote the safe and rational use of 
HMs. In understanding the patient safety and use of 
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herbal medicine from users’ perspective, different 
themes and sub-themes emerged in this study, (Table 1, 
Figures 1 and 2). 
It was observed that real-life expression of efficacy 
from the users’ own feelings and physiological changes 
were relatively difficult, as well as affected by many 
factors. Many users vividly expressed what they meant 
by a medication being effective. To express HMPs 
efficacy, two interviewees used weird signs such as 
“sweating” or “increased sickness intensity”.  This 
expression just expanded the belief factor and tradition 
in herbal medicine (HM). In this study, some users 
believed good herbal preparations were more effective 
and safer than pharmaceutical drugs. This finding is 
consistent with a recent study in Ghana by Aziato and 
Antwi [21].  
Evaluation or grading of efficacy from partial to very 
effective was difficult for informants except for one 
who had done laboratory tests after using HMP.  
According to her, her sugar level decreased but not as 
low as expected. This observation indicates the 
variation between assessing efficacy using patients’ 
own senses and feelings than when using scientific 
methods. HMs’ better effectiveness contradicts 
available scientific evidence [18]; less than 20% of the 
over 2000 herbal preparations and supplements were 
found by Bent to be effective scientifically. Recent 
research [6], identified that the efficacies of all the top-
5 antimalarial herbal preparations used in Central, 
Western and Greater Accra regions of Ghana were 
below WHO standard. Though the HMPs all reduced 
the level of parasitaemia to some extent, they were 
inadequate to be considered effective by WHO. This 
efficacy variation could partly be due to the holistic 
nature of the effect of HMPs compared to the targeted 
pharmaceutical drugs. Most scientific methods are 
designed to assess efficacy using parameters including 
specific cells, organs, tissues and pathogens. It is 
therefore recommended that further studies be carried 
out to assess the cause of the inconsistencies in the 
efficacies between the HMPs and the pharmaceutical 
drugs and to come out with a rigorous real-life 
assessment method of the efficacy of HMs to get the 
real-life picture of these medications. 
Most participants in this study believed HMs were 
moderately expensive; some being more expensive than 
pharmaceutical medicines. A similar trend was 
identified in Australia by Mcintyre et al [22]. This 
finding contradicts WHO position on HMs, which 
considers the use of HMs to be an affordable means of 
treatment [23]. This expense could be due to the 
subsidization of essential medicines in Ghana by 
international donors and the free provision of 
pharmaceutical medicines under the National Health 
Insurance Scheme (NHIS). The scheme provides free 
pharmaceutical medicines to patients under its 
coverage. HMPs did not benefit from any of these 
policies and might be considered expensive. 
According to experiences shared by users, HMs are seen 
to be a ‘slow but sure’ way of treatment. They believe 
HMs are slow but can cure diseases while 
pharmaceutical medications are quick but best used to 
manage not necessarily cure diseases. Mcintyre and 
colleagues identified that this ‘slow but sure’ belief 
deters some patients from using HMs [22]. Aziato and 
Antwi [21] on the other hand, found this belief to be a 
motivator for some Ghanaians to use HMs. In this study, 
however, users saw it as a motivator and this correlated 
well with Aziato and Antwi’s findings. This belief could 
partly explain why some users use HMs after 
pharmaceutical drugs administration to get the quick 
effects from the pharmaceutical drug and to ‘cure the 
health problem’ with the HMs. Herb-pharmaceutical 
combined drug use were very common among the 
interviewees. This study emphasizes that some 
sicknesses can only be managed or treated with HMs. 
The dissatisfaction of some Ghanaians with the 
outcome from pharmaceutical medicines were 
identified in this study as some of the important factors 
increasing people’s faith in HMs. The finding correlates 
with that of Peltzer and colleagues [3] who found a 
similar trend of increased trust in HMs. 
Adulteration is a common but serious problem in herbal 
medicine worldwide, whereby HMPs are found to 
contain synthetic prescription drugs as chemical 
adulterants intentionally introduced [24]. Fake herbal 
products are those that have either been wholly or partly 
substituted with less/ inactive substances, synthetic 
drugs or are mislabelled. The practice is done by 
producers with the idea of improving the efficacy, 
misinform the public and to sell sham or inactive herbal 
products to the public. The illegal production, sale and 
distribution of fake drugs represents over 50% of the 
pharmaceutical market in several African countries 
[25]. Fake HMPs on the market were a major concern 
to many in this study, which adds to the global health 
problem of fake medications, in both pharmaceutical 
and herbal medicines alike [24]. The awareness of fake 
preparations in the market led many users in this study, 
to be cautious of the efficacy of herbal medicine. Thus, 
HMPs are effective when one gets unadulterated 
versions from the market. 
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Some users expressed dissatisfaction with the market 
flooded with herbal preparations. The surge in HMPs 
could be due to market availability and increased 
reliance on herbal medicine. It might also be due to the 
urge to come out with new herbal products to combat 
the ever-increasing diseases affecting the public. Some 
users made the assertion that HMs are non-chemical, 
naturally extracted and are safe. This is an erroneous 
belief and it contradicts available scientific knowledge 
[14,15, 26,27]. Adverse health effects including chronic 
kidney disease, stomach swollen, constipation, nausea, 
headache and dizziness were reported among some 
informants in this study. The findings expand the 
evidence that HMs are generally safe, but they could 
cause adverse health problems [7].  
It was observed in this study that HM users find it 
difficult to voluntarily tell the general practitioners (GP) 
of their usage of HMs during hospital visits. This 
finding is in conformity with previous studies [22]. Two 
reasons were identified in this study to be the possible 
causes of the communication barrier between the 
physicians and the HM users; the first is “shyness” on 
the part of the users and the second is the “feeling of 
being condemned by the physician”. Shyness, because 
in the past Ghanaians associated HM with spirituality 
and a HM user was believed to be a believer of those 
traditions or spiritualism. Such beliefs and perceptions 
are changing in recent years giving rise to an increase in 
patronage among the old and the youth (mean age of 
users in this study was 47.8 ± 14.2 and participants 
ranged from 23 to 80 years). The feeling of being 
condemned by physicians might be due to users’ 
previous experiences with physicians on this matter or 
probably just a wrong notion about the physicians. 
Physicians can initiate discussion on this topic during 
visitations and guide users on the safe use of their herbal 
preparations since HM has become a fabric in the health 
care system in Ghana and has come to stay.  
Conclusion 
This study has provided some insight into the real-life 
experiences of selected Ghanaians with some of the 
commonly used HMPs in Kumasi. “Shyness” and the 
“feeling of being condemned by the physician” were 
identified to be the possible causes of the 
communication barrier between the physicians and the 
HM users. Concomitant use of HMPs and orthodox 
drugs was common especially among patients with 
chronic diseases and for treatment of malaria. Observed 
adverse effects based on informants’ experiences were 
generally non-severe and minimal. Only 5.4% of 
participants had experienced moderate to severe adverse 
effects. We recommend physicians to initiate discussion 
on this topic during consultations and guide users on 
safe use of these HMPs. In the face of perceived 
proliferation and adulteration of HMPs as reported by 
users in this study, regulatory authorities need to bring 
some sanity into the herbal industry in Ghana. While 
most informants claimed HMs were generally safe and 
effective, others had unpalatable experiences with 
serious adverse health effects. We recommend therefore 
that large-scale post-market surveillance is conducted 
throughout the entire country regularly for proper 
documentation of safety, efficacy and adverse events on 
all HMPs on the market. We also recommend that all 
HMPs should be subjected to scientific evaluation for 
efficacy and safety prior to registration or approval by 
the Food and Drugs Authority (FDA) while we also 
continue to advocate the cautious use of all HMPs on 
the market.  
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